Xortx Therapeutics Inc.

Biotechnology • Healthcare • Calgary, AB, United States • XRTX (NCM)

XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.

403 455 7727 3710 – 33rd Street NW, Calgary, AB T2L 2M1, Canada

Stock Performance (90 Days)

Data through Dec 26, 2025

Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

XORTX Therapeutics Inc. (XRTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

StocksToTrade • Jan 2

XORTX Announces Pioneering Research on Genome-Wide - GlobeNewswire

GlobeNewswire • Dec 31

Huge gout genetics study highlights target in kidney disease research - Stock Titan

Stock Titan • Dec 31

XORTX Announces Pricing of US$1.1 Million Registered Direct Offering - Yahoo Finance

Yahoo Finance • Oct 21

Why Is XORTX Therapeutics Stock (XRTX) Up 20% Today? - TipRanks

TipRanks • Oct 17

Other Biotechnology Companies

Vertex Pharmaceuticals Inc. / MA

$118.68B market cap

Regeneron Pharmaceuticals, Inc.

$82.72B market cap

Alnylam Pharmaceuticals, Inc.

Frequently Asked Questions

Has XORTX Therapeutics Inc. had layoffs?

No layoff events have been recorded for XORTX Therapeutics Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.

What industry is XORTX Therapeutics Inc. in?

XORTX Therapeutics Inc. operates in the Biotechnology industry, within the Healthcare sector.

Is XORTX Therapeutics Inc. a publicly traded company?

Yes, XORTX Therapeutics Inc. is publicly traded under the ticker symbol XRTX on the NCM. The company has a market capitalization of approximately $0.00 billion.

Where is XORTX Therapeutics Inc. headquartered?

XORTX Therapeutics Inc. is headquartered in Calgary, AB, United States at 3710 – 33rd Street NW, Calgary, AB T2L 2M1, Canada.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.